Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the workflow from biopsy to diagnosis. The company is dedicated to advancing cancer diagnostics and improving lives through innovative technologies.
With over 150 years of innovation, Leica Biosystems offers a comprehensive portfolio spanning histology, IHC & ISH, digital pathology, and research solutions. Their mission is supported by a vision of providing comprehensive insights in cancer diagnosis from translational research to patient treatment.
The company focuses on delivering reliable results through integrated systems, including tissue processing, staining, microscopy, and digital imaging solutions used in both clinical and research settings.
